Literature DB >> 2419593

Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals.

K S Steimer, K W Higgins, M A Powers, J C Stephans, A Gyenes, C George-Nascimento, P A Luciw, P J Barr, R A Hallewell, R Sanchez-Pescador.   

Abstract

Sera from the majority of individuals that were positive in an enzyme-linked immunosorbent assay (ELISA) retrovirus (ARV), an isolate of the for antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV), an isolate of the retrovirus identified as the etiologic agent of AIDS, were found to react with a 31,000-dalton protein (p31) in virus Western blot assays. To determine if this 31,000-dalton immunoreactive species originated from the putative endonuclease region of the polymerase (pol) gene of ARV, we cloned this portion of pol into bacterial expression vectors for direct expression and for expression as a fusion protein with human superoxide dismutase. Transformants from both constructions expressed immunoreactive protein detected in immunoblots with an AIDS patient's serum. Extracts from transformants expressing these sequences competed with the binding of antibodies from AIDS patients' sera to the 31,000-dalton protein in virus immunoblots, confirming that viral p31 originated from the endonuclease domain of the ARV polymerase gene. The superoxide dismutase-p31 fusion protein was purified, and an ELISA for detecting antibodies to p31 was developed. The majority (95%) of serum samples obtained from individuals seropositive in the virus ELISA were also positive in the p31 antibody ELISA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419593      PMCID: PMC252869     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information.

Authors:  M Zuker; P Stiegler
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

4.  Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus.

Authors:  C Saxinger; R C Gallo
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

5.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

6.  The tac promoter: a functional hybrid derived from the trp and lac promoters.

Authors:  H A de Boer; L J Comstock; M Vasser
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus.

Authors:  L Montagnier; F Clavel; B Krust; S Chamaret; F Rey; F Barré-Sinoussi; J C Chermann
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

8.  Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.

Authors:  M J Zoller; M Smith
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  22 in total

1.  Identification of a uniquely immunodominant, cross-reacting site in the human immunodeficiency virus endonuclease protein.

Authors:  E Björling; G Utter; P Stålhandske; E Norrby; F Chiodi
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

3.  A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta.

Authors:  A J Weiner; Q L Choo; K S Wang; S Govindarajan; A G Redeker; J L Gerin; M Houghton
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.

Authors:  V L Ng; C S Chiang; C Debouck; M S McGrath; T H Grove; J Mills
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.

Authors:  N Manca; F di Marzo Veronese; D D Ho; R C Gallo; M G Sarngadharan
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

6.  Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage.

Authors:  C A Boucher; M H de Jager; C Debouck; L G Epstein; F de Wolf; T F Wolfs; J Goudsmit
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

7.  Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.

Authors:  A D Leavitt; R B Rose; H E Varmus
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.

Authors:  R M Thorn; G A Beltz; C H Hung; B F Fallis; S Winkle; K L Cheng; D J Marciani
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

9.  Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells.

Authors:  G A Keller; T G Warner; K S Steimer; R A Hallewell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

10.  Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.

Authors:  D S Burke; R R Redfield; P Putman; S S Alexander
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.